Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1996 Apr 15;154(8):1155–1158.

The emerging role of the physician in genetic counselling and testing for heritable breast, ovarian and colon cancer.

K M Taylor 1, M J Kelner 1
PMCID: PMC1487682  PMID: 8612250

Abstract

As a genetic testing for susceptibility to breast, ovarian and colon cancer becomes more readily available, physicians are faced with an increasing demand for information about inherited cancer risk. Because advances in treatment have not kept pace with advances in predictive testing, the provision of genetic counselling and testing marks a departure from the traditional role of the physician. A systematic framework is needed within which the physician's emerging role in predictive testing for heritable cancer can be delineated. The development of such a framework will require collaboration among professionals in a range of scientific disciplines, as well as the suspension of traditional assumptions about the physicians role.

Full text

PDF
1155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Breo D. L. Altered fates--counseling families with inherited breast cancer. JAMA. 1993 Apr 21;269(15):2017–2022. doi: 10.1001/jama.269.15.2017. [DOI] [PubMed] [Google Scholar]
  2. Cole D. E., Gallinger S., McCready D. R., Rosen B., Engel J., Malkin D. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today? CMAJ. 1996 Jan 15;154(2):149–155. [PMC free article] [PubMed] [Google Scholar]
  3. Garver K. L., Garver B. Eugenics: past, present, and the future. Am J Hum Genet. 1991 Nov;49(5):1109–1118. [PMC free article] [PubMed] [Google Scholar]
  4. Geller G., Tambor E. S., Bernhardt B. A., Chase G. A., Hofman K. J., Faden R. R., Holtzman N. A. Physicians' attitudes toward disclosure of genetic information to third parties. J Law Med Ethics. 1993 Summer;21(2):238–240. doi: 10.1111/j.1748-720x.1993.tb01246.x. [DOI] [PubMed] [Google Scholar]
  5. Kahn P. Genetic diversity project tries again. Science. 1994 Nov 4;266(5186):720–722. doi: 10.1126/science.7973621. [DOI] [PubMed] [Google Scholar]
  6. King M. C., Rowell S., Love S. M. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA. 1993 Apr 21;269(15):1975–1980. [PubMed] [Google Scholar]
  7. Lerman C., Daly M., Masny A., Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994 Apr;12(4):843–850. doi: 10.1200/JCO.1994.12.4.843. [DOI] [PubMed] [Google Scholar]
  8. Lerman C., Daly M., Walsh W. P., Resch N., Seay J., Barsevick A., Birenbaum L., Heggan T., Martin G. Communication between patients with breast cancer and health care providers. Determinants and implications. Cancer. 1993 Nov 1;72(9):2612–2620. doi: 10.1002/1097-0142(19931101)72:9<2612::aid-cncr2820720916>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  9. Lippman A. Led (astray) by genetic maps: the cartography of the human genome and health care. Soc Sci Med. 1992 Dec;35(12):1469–1476. doi: 10.1016/0277-9536(92)90049-v. [DOI] [PubMed] [Google Scholar]
  10. Markel H. The stigma of disease: implications of genetic screening. Am J Med. 1992 Aug;93(2):209–215. doi: 10.1016/0002-9343(92)90052-d. [DOI] [PubMed] [Google Scholar]
  11. Pelias M. Z. Duty to disclose in medical genetics: a legal perspective. Am J Med Genet. 1991 Jun 1;39(3):347–354. doi: 10.1002/ajmg.1320390320. [DOI] [PubMed] [Google Scholar]
  12. Sandler R. S., Holland K. L., Brooks E., Konrad T. R., Guild P. A. Physicians' opinions and use of colorectal cancer screening procedures. N C Med J. 1989 Aug;50(8):452–455. [PubMed] [Google Scholar]
  13. Spodick D. H. Randomized controlled clinical trials: The behavioral case. JAMA. 1982 Apr 23;247(16):2258–2260. [PubMed] [Google Scholar]
  14. Taylor K. M. "Telling bad news": physicians and the disclosure of undesirable information. Sociol Health Illn. 1988 Jun;10(2):109–132. doi: 10.1111/j.1467-9566.1988.tb00001.x. [DOI] [PubMed] [Google Scholar]
  15. Taylor K. M., Feldstein M. L., Skeel R. T., Pandya K. J., Ng P., Carbone P. P. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol. 1994 Sep;12(9):1796–1805. doi: 10.1200/JCO.1994.12.9.1796. [DOI] [PubMed] [Google Scholar]
  16. Whittaker L. A. The implications of the Human Genome Project for family practice. J Fam Pract. 1992 Sep;35(3):294–301. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES